5 May – Webinar in connection with year-end report
Alligator hosted a webinar and conference call for investors, analysts, and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the interim report. The presentation was followed by a Q&A session.
The call will be held in English and a recording can be requested via ir@alligatorbioscience.com.
LATEST NEWS
Notice of extraordinary general meeting in Alligator Bioscience AB
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …
Alligator discontinues independent development of mitazalimab for a strategic refocus on the HLX22 project, announces a rights issue of units of approximately SEK 125.6 million and raises bridge loans
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, …
Alligator announces first patient dosed in investigator-initiated study of intratumoral mitazalimab in early-stage breast cancer
First patient dosed in an investigator-initiated trial evaluating intratumoral mitazalimab, with or without intratumoral nivolumab Study eva …